The tattoos on Zandile Simelane's arms tell a story that most people can’t read. Hidden beneath the delicate blue ink of ...

We talked to experts in obesity, tobacco, artificial intelligence, HIV, TB and the NHI to find out what we can expect — and ...

We’ve put together a short list of our favourite essays and longform stories. These stories don't always make the headlines but they often take us deeper into the people and places on the frontlines ...

We tell a good story with the science to back it. Support great journalism today.

Professors Hoosen Coovadia and Salim Abdool Karim, two of SA's foremost HIV researchers, were recently the health department's greatest enemies.

On Saturday, the US state department issued details of who qualifies for a limited waiver during the Trump administration’s 90-day pause of foreign aid. The freeze has resulted in the temporary close ...

In today’s newsletter, Mia Malan explains why there were empty seats at this year’s Conference on Retroviruses and Opportunistic Infections (Croi). Sign up for our newsletter today. In Yerba Buena ...

In today’s newsletter, Mia Malan explains how US President Donald Trump ordered USAID-funded HIV organisations in SA to shut down. Sign up for our newsletter today. Pepfar-funded HIV organisations in ...

In today’s newsletter, Mia Malan explain why HIV scientists and government are once again pitted against each other. Sign up for our newsletter today. In the leafy office park not far from Charlotte ...

In today’s newsletter, Mia Malan explains why Gilead Sciences and Sahpra are talking about lenacapavir. Sign up for our newsletter now. Gilead Sciences, the maker of a twice-a-year anti-HIV injection, ...

In today’s newsletter, Mia Malan introduces a modelling study that shows how lenacapavir could end Aids by 2032. Sign up for our newsletter today. “If HIV could talk, it would say ‘thank God for the ...